C.Diff Flashcards

1
Q

Features of infection

A
  • gram +ve
  • spore forming
  • anaerobic bacillus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Route of transmission

A

faecal-oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where does CDI colonise

A

LI
*when normal flora is reduced by Abs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where is CDI most commonly acquired

A

nosocomical

i.e. hospital acquired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors associted with CDI

A
  • x8-10 higher after antimicrobial therapy e.g clindamycin
  • patients over 65 yrs have x5-10 risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What part of body is affected

A

Any part of colon

*mostly the distal segment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Main protective barrier against CDI

A

normal intestinal microflora

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Associated conditions

A
  • Pseudomembranous colitis (PMC)
  • antibiotic associated diarrhea (AAD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathogenesis

A
  • in intestine, bile acids play important role in induction of C.diff spore germination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary bile and secondary bile conc. in healthy vs C.diff patients

A

primary bile (cholic acid)
- higher in feaces of CDI patients

secondary bile (deoxycholic acid)
- higher in faeces of healthy patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What causes virulence of C.diff

A
  • not invasive
  • virulence caused by enzymes (collagenase, hyaluronidase)
  • leads to damage of epi cell cytoskeleton, disruption of tight junctions, fluid secretion, NF adhesion, local inflammation
  • breakdown of gut barrier integrity and loss of functionality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Toxins

A

A (enterotoxin)
B (cytotoxin)

  • transported to cytoplams -> activate Rho family of GTPases
  • inactivates G protein
  • impaires actin polymerisation
  • loss of function and shape in mucousal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Strains of c.diff

A

Toxin A negative
Toxin B positive
Binary toxin (6% strains)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Binary toxin

A
  • one ligand to a receptor
  • one enzymatically active toxic component inside host cell
  • displays actin specific activity that leads to cytoskeletal disorganisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

New strain

A

C.diff 027

  • framshift stop codon in tdcC negative regulator
  • hyperexpresses A and B toxins
  • all isolates are +ve for binary toxin
  • increased sporulation rate
  • resistant to floroquinolones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnosis

A
  • ELISA assays

Gold standard
- detection of toxicity of stool filtrates for cell cultured cells (often fibroblats)
- cytopathic effect blocked by Abs to toxin A or B

17
Q

Culturing C.diff

A
  • cycloserine-cefoxitin fructose agar (CCFA)
18
Q

Treatment

A
  • cessation of antibiotics
  • witch to vancomycin or fidaxomicin
19
Q

Control of C.diff

A
  • restrict specific Abs (cephalosporins & clindamycin) in elderly
  • prevent transmission of spores (hygiene)
  • isolate cases
  • surveillance
20
Q

Potential new therapies

A
  • probiotics
  • FMT
21
Q

mAb

A

Bezlotoxumab

  • against c.diff toxin B
  • reduce risk of recurrent c.diff
  • binds toxin B with equilibrium dissociation constant (Kd) of <1x10-9M
  • inhibits binding of toxin B -> prevents effects on mammalian cells